Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

NCT05266417 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: INS-GSH
DRUG: Matched Placebos

Sponsor

Gateway Institute for Brain Research